[Application of RNAi technology to knockdown gene expression in vivo in mammalians]
- PMID: 15285417
[Application of RNAi technology to knockdown gene expression in vivo in mammalians]
Abstract
Post-transcriptional gene silencing (PTGS) initiated by dsRNA, which result in specific degradation of homologous mRNA, is called RNAi. The discovery of RNAi greatly intrigued researchers, and was followed by a flood of papers that described the phenomenon and mechanism of RNAi. More excitingly, RNAi has recently been developed into a new tool, showing promising role in reverse genetics, gene therapy and anti-viral infection. This review provides the progress of the application of RNAi technology in mammalian animals.
Similar articles
-
[RNA interference and its possible use in cancer therapy].Bull Cancer. 2004 Jan;91(1):15-8. Bull Cancer. 2004. PMID: 14975801 Review. French.
-
[Gene silencing RNAi technology: possible application to therapy].Harefuah. 2006 Feb;145(2):156-9, 163. Harefuah. 2006. PMID: 16509424 Hebrew.
-
Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.Gene Ther. 2004 Aug;11(16):1241-8. doi: 10.1038/sj.gt.3302324. Gene Ther. 2004. PMID: 15292914 Review.
-
Downregulation enhanced green fluorescence protein gene expression by RNA interference in mammalian cells.RNA Biol. 2004 May;1(1):74-7. Epub 2004 May 22. RNA Biol. 2004. PMID: 17194936
-
RNA interference--significance and applications.Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):39-46. Arch Immunol Ther Exp (Warsz). 2005. PMID: 15761375 Review.